The following IPOs are expected to price this week:
Acquity Group (AQ), which provides e-commerce and online marketing consulting for consumer brands, plans to raise $50 million by offering 5.6 million shares at a price range of $8.00 to $10.00. At the midpoint of the proposed range, Acquity Group would command a market value of $212 million. Acquity Group, which was founded in 2001, booked $107 million in sales over the last 12 months. The company, whose primary operations are based in Chicago (its executive offices are located in Hong Kong), plans to list on the NYSE under the symbol AQ. Citi and Oppenheimer & Co. are the joint bookrunners on the deal.
Ares Commercial Real Estate (ACRE), an Ares Management-owned REIT focused on middle-market commercial real estate assets, plans to raise $150 million by offering 7.7 million shares at a price range of $19.00 to $20.00. At the midpoint of the proposed range, Ares Commercial Real Estate would command a market value of $180 million. Ares Commercial Real Estate, which was founded in 2011, plans to list on the NYSE under the symbol ACRE. Wells Fargo Securities, Citi, BofA Merrill Lynch and J.P. Morgan are the joint bookrunners on the deal.
China Auto Rental (CARH), which operates the largest car rental service in China, plans to raise $127 million by offering 11.0 million shares at a price range of $10.50 to $12.50. At the midpoint of the proposed range, China Auto Rental would command a market value of $847 million. China Auto Rental, which was founded in 2007, booked $123 million in sales over the last 12 months. The Beijing, China-based company plans to list on the NASDAQ under the symbol CARH. Morgan Stanley, J.P. Morgan and BofA Merrill Lynch are the joint bookrunners on the deal.
Edgen Group (EDG), a global distributor of specialty products to the oil and natural gas markets, plans to raise $225 million by offering 15.0 million shares at a price range of $14.00 to $16.00. At the midpoint of the proposed range, Edgen Group would command a market value of $643 million. Edgen Group, which was founded in 2005, booked $1.7 billion in sales over the last 12 months. The Baton Rouge, LA-based company plans to list on the NYSE under the symbol EDG. Jefferies & Co., Morgan Stanley and Citi are the joint bookrunners on the deal.
Enerkem (NRKM), which has developed a process that converts municipal waste into cellulosic ethanol, plans to raise $131 million by offering 7.3 million shares at a price range of $17.00 to $19.00. At the midpoint of the proposed range, Enerkem would command a market value of $534 million. Enerkem, which was founded in 2000, booked $3 million in sales over the last 12 months. The Montreal, Canada-based company plans to list on the NASDAQ under the symbol NRKM. Goldman Sachs, Credit Suisse and BMO Capital Markets are the joint bookrunners on the deal.
Envivio (ENVI), which enables network providers to deliver high-quality video across multiple devices, plans to raise $85 million by offering 7.8 million shares at a price range of $10.00 to $12.00. At the midpoint of the proposed range, Envivio would command a market value of $325 million. Envivio, which was founded in 2000, booked $51 million in sales over the last 12 months. The South San Francisco, CA-based company plans to list on the NASDAQ under the symbol ENVI. Goldman Sachs, Deutsche Bank Securities and Stifel Nicolaus Weisel are the joint bookrunners on the deal.
Luca Technologies (LUCA), which uses biotechnology to create and produce coalbed methane (natural gas), plans to raise $102 million by offering 8.5 million shares at a price range of $11.00 to $13.00. At the midpoint of the proposed range, Luca Technologies would command a market value of $352 million. Luca Technologies, which was founded in 2003, booked $1 million in sales over the last 12 months. The Golden, CO-based company plans to list on the NASDAQ under the symbol LUCA. Citi, Piper Jaffray and Raymond James are the joint bookrunners on the deal.
Supernus Pharmaceuticals (SUPN), a former Shire subsidiary developing improved drug formulations for epilepsy and ADHD, plans to raise $75 million by offering 5.8 million shares at a price range of $12.00 to $14.00. At the midpoint of the proposed range, Supernus Pharmaceuticals would command a market value of $263 million. Supernus Pharmaceuticals, which was founded in 2005, booked $1 million in sales over the last 12 months. The Rockville, MD-based company plans to list on the NASDAQ under the symbol SUPN. Citi and Piper Jaffray are the joint bookrunners on the deal.
Renaissance Capital will have Pre-IPO Research available on each of these upcoming IPOs prior to its pricing.
Last week, there were 6 IPO pricings. Splunk (SPLK), which provides software for large scale indexing of unstructured data, was the week's winner, ending up 113% from its IPO price.
